Larisa J. Geskin

6.5k total citations
162 papers, 2.3k citations indexed

About

Larisa J. Geskin is a scholar working on Dermatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Larisa J. Geskin has authored 162 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Dermatology, 57 papers in Oncology and 56 papers in Pathology and Forensic Medicine. Recurrent topics in Larisa J. Geskin's work include Cutaneous lymphoproliferative disorders research (95 papers), Lymphoma Diagnosis and Treatment (37 papers) and Fungal Infections and Studies (29 papers). Larisa J. Geskin is often cited by papers focused on Cutaneous lymphoproliferative disorders research (95 papers), Lymphoma Diagnosis and Treatment (37 papers) and Fungal Infections and Studies (29 papers). Larisa J. Geskin collaborates with scholars based in United States, United Kingdom and Italy. Larisa J. Geskin's co-authors include Adriana T. Lopez, Oleg E. Akilov, Patrizia Fuschiotti, Megan H. Trager, Rebecca G. Pomerantz, Louis D. Falo, Brittany Dulmage, Sara Viragova, Donna B. Stolz and Faramarz H. Samie and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Larisa J. Geskin

146 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larisa J. Geskin United States 27 1.2k 830 781 776 648 162 2.3k
Maria Teresa Fierro Italy 31 1.1k 0.9× 934 1.1× 1.0k 1.3× 1.1k 1.4× 666 1.0× 132 2.9k
Elena Netchiporouk Canada 24 972 0.8× 468 0.6× 441 0.6× 477 0.6× 416 0.6× 116 2.0k
Sunil Reddy United States 24 822 0.7× 704 0.8× 746 1.0× 1.1k 1.4× 509 0.8× 72 2.7k
P Souteyrand France 25 721 0.6× 585 0.7× 539 0.7× 862 1.1× 452 0.7× 92 2.1k
Ivor Caro United States 25 813 0.7× 316 0.4× 836 1.1× 572 0.7× 505 0.8× 65 2.2k
Francine M. Foss United States 32 1.4k 1.1× 1.2k 1.4× 1.7k 2.2× 1.0k 1.3× 582 0.9× 128 3.7k
Doina Ivan United States 31 1.4k 1.1× 616 0.7× 325 0.4× 1.7k 2.2× 914 1.4× 136 3.1k
Julia Scarisbrick United Kingdom 33 2.9k 2.3× 1.7k 2.1× 1.4k 1.8× 937 1.2× 1.6k 2.4× 123 4.2k
Ryan A. Wilcox United States 32 992 0.8× 1.4k 1.7× 2.5k 3.2× 2.0k 2.6× 534 0.8× 125 4.4k
Hisashi Uhara Japan 32 894 0.7× 261 0.3× 510 0.7× 2.1k 2.7× 873 1.3× 158 3.2k

Countries citing papers authored by Larisa J. Geskin

Since Specialization
Citations

This map shows the geographic impact of Larisa J. Geskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa J. Geskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa J. Geskin more than expected).

Fields of papers citing papers by Larisa J. Geskin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larisa J. Geskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa J. Geskin. The network helps show where Larisa J. Geskin may publish in the future.

Co-authorship network of co-authors of Larisa J. Geskin

This figure shows the co-authorship network connecting the top 25 collaborators of Larisa J. Geskin. A scholar is included among the top collaborators of Larisa J. Geskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larisa J. Geskin. Larisa J. Geskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gordon, Emily R., et al.. (2024). Exploring Cutaneous Lymphoproliferative Disorders in the Wake of COVID-19 Vaccination. SHILAP Revista de lepidopterología. 4(3). e367–e367.
2.
Gordon, Emily R., Megan H. Trager, Connor J. Stonesifer, et al.. (2024). Maintenance therapy for CTCL: importance for prevention of disease progression. Leukemia & lymphoma. 65(12). 1883–1890.
3.
Geskin, Larisa J., Christiane Querfeld, Emmilia Hodak, et al.. (2024). Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides. Frontiers in Medicine. 10. 1298988–1298988. 1 indexed citations
4.
Carvajal, Richard D., et al.. (2024). Cutaneous type IV hypersensitivity reaction following tebentafusp treatment for uveal melanoma. Dermatology Online Journal. 29(6).
5.
Jiang, Tony, Oleg Kruglov, A K Virmani, et al.. (2023). Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome. Journal of Investigative Dermatology. 144(5). 1088–1098. 4 indexed citations
6.
Geskin, Larisa J., et al.. (2023). Racial and ethnic disparities in the perception of respect from physicians among skin cancer patients in the United States. JAAD International. 11. 78–82. 2 indexed citations
7.
Fahmy, Lara M., et al.. (2023). 212 An un-masking cream: discovery of T-cell dyscrasia after treatment with tapinarof. Journal of Investigative Dermatology. 143(11). S368–S368. 1 indexed citations
8.
Gordón, Elizabeth, et al.. (2023). 245 A rare case of erythrodermic sarcoidosis with systemic involvement after COVID-19 vaccination. Journal of Investigative Dermatology. 143(11). S373–S373.
9.
Zhao, Lei, Connor J. Stonesifer, Jay Daniels, et al.. (2022). The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion. Journal of Investigative Dermatology. 142(12). 3253–3261.e4. 2 indexed citations
10.
Herrera, Alberto, Anthony Cheng, Eleni P. Mimitou, et al.. (2021). Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures. Blood. 138(16). 1456–1464. 45 indexed citations
11.
Cortés, José R., S. Aidan Quinn, Marta Sánchez-Martín, et al.. (2021). Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 141(12). 2908–2920.e7. 17 indexed citations
12.
Porcu, Pierluigi, Stacie Hudgens, Sarah McCue Horwitz, et al.. (2020). Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(2). 97–105. 20 indexed citations
13.
Bouaziz, Jérôme, Maxime Battistella, Jacqueline Rivet, et al.. (2020). Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma. Acta Dermato Venereologica. 100(15). adv00229–adv00229. 1 indexed citations
14.
Queen, Dawn, et al.. (2020). Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma. Blood. 136(15). 1748–1759. 25 indexed citations
15.
Tabib, Tracy, et al.. (2019). Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors. Clinical Cancer Research. 25(14). 4443–4454. 85 indexed citations
16.
Trager, Megan H., Dawn Queen, Faramarz H. Samie, et al.. (2019). Advances in Prevention and Surveillance of Cutaneous Malignancies. The American Journal of Medicine. 133(4). 417–423. 21 indexed citations
17.
Lopez, Adriana T., Richard D. Carvajal, & Larisa J. Geskin. (2018). Secondary Prevention Strategies for Nonmelanoma Skin Cancer.. PubMed. 32(4). 195–200. 16 indexed citations
18.
Geskin, Larisa J., et al.. (2015). Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma. JAAD Case Reports. 1(2). 93–95. 2 indexed citations
19.
Schowalter, Michael K., et al.. (2013). Breast Implant–Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders. The Oncologist. 18(3). 301–307. 49 indexed citations
20.
Geskin, Larisa J., et al.. (2006). CUTANEOUS B-CELL PSEUDOLYMPHOMA DUE TO PARAPHENYLENEDIAMINE. Dermatitis. 17(2). 98–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Teresa Fierro Breakdown of academic impact, for papers by Elena Netchiporouk Breakdown of academic impact, for papers by Sunil Reddy Breakdown of academic impact, for papers by P Souteyrand Breakdown of academic impact, for papers by Ivor Caro Breakdown of academic impact, for papers by Francine M. Foss Breakdown of academic impact, for papers by Doina Ivan Breakdown of academic impact, for papers by Julia Scarisbrick Breakdown of academic impact, for papers by Ryan A. Wilcox Breakdown of academic impact, for papers by Hisashi Uhara
Rankless by CCL
2026